PHASE HOLOGRAPHIC IMAGING PHI AB Financials Phase Holographic Imaging PHI AB
Equities
PHI
SE0005504636
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.46 SEK | -4.44% |
|
-.--% | +8.39% |
| 05-17 | Phase Holographic Imaging Obtains SEK7 Million Loan Agreement | MT |
| 03-27 | Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
Valuation
| Fiscal Period: April | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 398 | 349.2 | 413.1 | 357 | 80.61 | 100.2 |
| Enterprise Value (EV) 1 | 401.6 | 331.2 | 400.8 | 364.6 | 104.4 | 117.3 |
| P/E ratio | -28.1 x | -14.5 x | -15.7 x | -15.2 x | -3.18 x | -4.24 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 89.4 x | 75.9 x | 109 x | 98.2 x | 9.87 x | 10.1 x |
| EV / Revenue | 90.3 x | 72 x | 105 x | 100 x | 12.8 x | 11.9 x |
| EV / EBITDA | -30.5 x | -14.9 x | -15.7 x | -14.8 x | -5.39 x | -5.87 x |
| EV / FCF | -33.2 x | -27.3 x | -30.2 x | -29.3 x | -1.95 x | 7.66 x |
| FCF Yield | -3.01% | -3.66% | -3.31% | -3.42% | -51.4% | 13.1% |
| Price to Book | 21.8 x | 9.27 x | 14.3 x | 66.3 x | 2.99 x | 26.9 x |
| Nbr of stocks (in thousands) | 11,670 | 13,747 | 14,395 | 14,395 | 14,395 | 20,453 |
| Reference price 2 | 34.10 | 25.40 | 28.70 | 24.80 | 5.600 | 4.900 |
| Announcement Date | 18-09-05 | 19-09-19 | 20-09-30 | 21-09-30 | 22-10-17 | 23-10-06 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: April | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.449 | 4.601 | 3.803 | 3.637 | 8.169 | 9.9 |
| EBITDA 1 | -13.17 | -22.18 | -25.46 | -24.7 | -19.38 | -20 |
| EBIT 1 | -13.84 | -22.78 | -26.05 | -25.29 | -19.82 | -20.35 |
| Operating Margin | -311.1% | -495.11% | -685.04% | -695.24% | -242.67% | -205.58% |
| Earnings before Tax (EBT) 1 | -14.12 | -23.05 | -26.31 | -23.51 | -25.38 | -23.18 |
| Net income 1 | -14.12 | -23.05 | -26.31 | -23.51 | -25.38 | -23.18 |
| Net margin | -317.33% | -500.98% | -691.9% | -646.38% | -310.7% | -234.19% |
| EPS 2 | -1.212 | -1.751 | -1.829 | -1.633 | -1.763 | -1.155 |
| Free Cash Flow 1 | -12.09 | -12.13 | -13.29 | -12.45 | -53.64 | 15.32 |
| FCF margin | -271.74% | -263.64% | -349.35% | -342.38% | -656.67% | 154.79% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 18-09-05 | 19-09-19 | 20-09-30 | 21-09-30 | 22-10-17 | 23-10-06 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: April | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 3.68 | - | - | 7.62 | 23.8 | 17.1 |
| Net Cash position 1 | - | 18 | 12.4 | - | - | - |
| Leverage (Debt/EBITDA) | -0.2793 x | - | - | -0.3085 x | -1.228 x | -0.8556 x |
| Free Cash Flow 1 | -12.1 | -12.1 | -13.3 | -12.5 | -53.6 | 15.3 |
| ROE (net income / shareholders' equity) | -57.1% | -82.4% | -79.1% | -137% | -157% | -151% |
| ROA (Net income/ Total Assets) | -24% | -37.8% | -39.3% | -54.7% | -31.2% | -27.5% |
| Assets 1 | 58.88 | 61.03 | 66.89 | 43 | 81.38 | 84.2 |
| Book Value Per Share 2 | 1.570 | 2.740 | 2.010 | 0.3700 | 1.870 | 0.1800 |
| Cash Flow per Share 2 | 0.1000 | 1.550 | 1.010 | 0.1600 | 0.1000 | 0.2600 |
| Capex 1 | 0.7 | 0.31 | 0.18 | - | 0.05 | 0.54 |
| Capex / Sales | 15.8% | 6.78% | 4.6% | - | 0.59% | 5.43% |
| Announcement Date | 18-09-05 | 19-09-19 | 20-09-30 | 21-09-30 | 22-10-17 | 23-10-06 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +8.39% | 15.8M | |
| -18.76% | 18.12B | |
| -41.90% | 2.87B | |
| +19.36% | 1.9B | |
| -1.05% | 1.65B | |
| +35.53% | 1.34B | |
| -16.83% | 957M | |
| -21.96% | 896M | |
| +7.95% | 841M | |
| +15.57% | 523M |
- Stock Market
- Equities
- PHI Stock
- Financials Phase Holographic Imaging PHI AB
